4.5 Article

Generation and Characterization of Induced Pluripotent Stem Cells and Retinal Organoids From a Leber's Congenital Amaurosis Patient With Novel RPE65 Mutations

期刊

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fnmol.2019.00212

关键词

reprogramming; differentiation; retinal organoids; RPE65 gene mutations; retinal degeneration

资金

  1. Natural Science Foundation of China [81570874, 81970842, 81600746]
  2. Science and Technology Project of Guangdong Province [2017B020230003]
  3. National Key R&D Program of China [2017YFA0104100, 2016YFC1101103]
  4. Guangzhou Science and Technology Project Fund [201803010078]
  5. Open Research Funds of the State Key Laboratory of Ophthalmology
  6. Fundamental Research Funds of the State Key Laboratory of Ophthalmology

向作者/读者索取更多资源

RPE65-associated Leber congenital amaurosis (LCA) is one of highly heterogeneous, early onset, severe retinal dystrophies with at least 130 gene mutation sites identified. Their pathogenicity has not been directly clarified due to lack of diseased cells. Here, we generated human-induced pluripotent stem cells (hiPSCs) from one putative LCA patient carrying two novel RPE65 mutations with c.200T> G (p.L67R) and c.430 NC (p.Y144H), named RPE65-hiPSCs, which were confirmed to contain the same mutations. The RPE65-hiPSCs presented typical morphological features with normal karyotype, expressed pluripotency markers, and developed teratoma in NOD-SCID mice. Moreover, the patient hiPSCs were able to differentiate toward retinal lineage fate and self-form retinal organoids with layered neural retina. All major retinal cell types including photoreceptor and retinal pigment epithelium (RPE) cells were also acquired overtime. Compared to healthy control, RPE cells from patient iPSCs had lower expression of RPE65, but similar phagocytic activity and VEGF secretion level. This study provided the valuable patient specific, disease targeted retinal organoids containing photoreceptor and RPE cells, which would facilitate the study of personalized pathogenic mechanisms of disease, drug screening, and cell replacement therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据